Navigation Links
Attention Deficit Hyperactivity Disorder Market (ADHD) Analysis & 2018 Forecasts in New Research Report at RnRMarketResearch.com
Date:6/6/2013

Dallas, Texas (PRWEB) June 06, 2013

The impending publication of the fifth edition of the American Psychiatric Association’s (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM-V) may affect diagnosis rates of conditions such as Attention-Deficit/Hyperactivity Disorder (ADHD), both in the US and worldwide.

European countries are increasingly adopting the US diagnostic criteria (DSM-IV), resulting in more and more diagnoses of ADHD. This may eventually result in a rise in ADHD diagnoses even further afield.

Although Europe trails behind the US in terms of market revenue, ADHD therapeutics markets are expected to show strong growth, with Spain predicted to witness a Compound Annual Growth Rate (CAGR) of 8% over 2012-2018, beating the US CAGR of 6% during the same future period. European markets have not yet neared the saturation point that ADHD therapeutics are facing in the US, and there is an optimistic view for ambitious growth in this region. The ADHD therapeutics market across France, Germany, Italy, Spain and the UK is predicted to reach approximately $182m in 2018.

Get a copy of this report @ http://www.rnrmarketresearch.com/adhd-therapeutics-market-to-2018-market-report.html

This report “ADHD Therapeutics Market to 2018 – New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment” provides insights into the up-and-coming trends of the ADHD market in seven major markets: the US, the top five European countries (France, Germany, Italy, Spain and the UK) and Japan. The report includes market forecasts to 2019, detailed pipeline analysis, in-depth profiling of the major products and details of recent industry deals.

Scope:
Current and future treatment and diagnosis trends for ADHD & market forecasts for ADHD across seven major markets.

Analysis of the developmental pipelines for ADHD and information on recent industry deals.

Reasons to Buy:
Understand how the ADHD market has developed and is continuing to develop within the featured markets.

Predict which products are likely to be most successful in the future and gain an understanding of the possible market available for specific products.

Purchase a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=99800

Browse more reports on Therapeutics Market @ http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics

About Us:
RnRMarketResearch.com (http://www.rnrmarketresearch.com/) is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.

Read the full story at http://www.prweb.com/releases/2018-ADHD-therapeutics/market-analysis-report/prweb10807757.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. You Survived Cancer: Now Pay Attention to Your Overall Health
2. Blood Clot Risk for Outpatients Needs More Attention: Study
3. Excessive sleepiness may be cause of learning, attention and school problems
4. Study finds drug warning labels need overhaul to better capture attention, convey information
5. Brain development is delayed in attention-deficit/hyperactivity disorder
6. Preschool children who can pay attention more likely to finish college
7. Pay Attention in Preschool, Graduate From College: Study
8. Lights off? International experts call attention to dangers of exposure to light at night
9. Attention, parents: UC research reveals a secret about your medicine cabinet
10. Study suggests increased diagnosis rate of attention-deficit/hyperactivity disorder at health plan
11. Yale researchers spot attention deficits in babies who later develop autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... ... February 05, 2016 , ... Give To Cure ... search for and donate to Give To Cure’s campaign that is crowdfunding clinical trials ... users make and share payments through a smart device. In 2015 alone, Venmo processed ...
(Date:2/5/2016)... ... February 05, 2016 , ... Pivot Point ... Best in KLAS: Software & Services for HIT Implementation Support & Staffing report ... independently ranks vendor performance by healthcare executives, managers and clinicians representing over 4,500 ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Justin Scott and Dr. ... Annual No Cost Dental Day to individuals in need. The event is scheduled to ... No Cost Dental Day is to provide dental care to community members in need. ...
(Date:2/5/2016)... ... February 05, 2016 , ... Dr. Ben Amini, a ... is now welcoming orthodontist, Dr. Amanda Cheng, to the practice. With the addition ... health care, including general dentistry, cosmetic treatments, periodontics, implant dentistry , endodontics, ...
(Date:2/5/2016)... ... February 05, 2016 , ... In sleep, when the ... a dream. A hallmark feature of patients with eating disorders is significant self-criticism, and ... disorder behaviors and obsessions are regarded as maladaptive means for coping with this unease, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)...  Venice,s newest laser clinic, Physicians Advanced ... kind in the area and specializes in the ... The physician-owned and operated laser clinic is taking ... with its revitalizing skin care approach, unprecedented eVisit ... technology. http://photos.prnewswire.com/prnh/20160204/329957 --> ...
(Date:2/5/2016)... , Feb. 5, 2016  Henry Schein, Inc. (NASDAQ: ... care products and services to office-based dental, animal health ... into an agreement to acquire a majority ownership interest ... and equipment in Brazil . ... in Blumenau, Brazil, Dental Cremer is the dental distribution business ...
(Date:2/4/2016)... Feb. 4, 2016  Edwards Lifesciences Corporation (NYSE: ... structural heart disease and critical care monitoring, announced today ... (ASR) agreement with Morgan Stanley & Co. LLC to ... is part of the Company,s previously authorized program to ... stock.  --> --> ...
Breaking Medicine Technology: